MindMotion PRO
Commercial- Indications
- Stroke, Neurological conditions
Company intelligence / Profile preview
MindMaze’s digital neurotherapeutic products—including FDA-cleared and CE-marked systems—are commercially available globally. Clinical studies have demonstrated efficacy in improving motor/cognitive outcomes post-stroke and other neurological conditions. The company partners with leading hospitals worldwide to deliver evidence-based teleneurorehabilitation at scale.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MindMaze.